Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cervical Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cervical Cancer
    ACOG Recommends Pap Tests for Cervical Cancer Screening Begin Later, With Lower Frequency - (DGNews)
    TopAbstracts in Cervical Cancer 11/12/2009 - (DGNews)
    Age-Specific Evaluation of HPV DNA Testing versus Cytology Screening - (DGNews)
    New Vaccine for Human Papillomavirus 16/18 Shows High Levels of Immunogenicity: Presented at IDSA - (DGDispatch)

    News archive

     Recent webcasts/CME - Cervical Cancer
      Update on HPV: Beyond Cervical Cancer

      Webcasts/CME archive

       Recent cases - Cervical Cancer
        A Rare Case of Cervical Tuberculosis Simulating Carcinoma Cervix: A Case Report
        Combination of Abducens Nerve Palsy and Ipsilateral Postganglionic Horner Syndrome as an Initial Manifestation of Uterine Cervical Cancer
        Chemotherapy Related Encephalopathy in a Patient With Stage IV Cervical Carcinoma Treated with Cisplatin and 5-Fluorouracil: A Case Report
        Serous Adenocarcinoma of the Fallopian Tube, Associated with Verrocous Carcinoma of the Uterine Cervix: A Case Report of Synchronic Rare Gynecological Tumors
        Preoperative Y-90 Microsphere Selective Internal Radiation Treatment for Tumor Downsizing and Future Liver Remnant Recruitment: A Novel Approach to Improving the Safety of Major Hepatic Resections

        Cases archive
          




        my personal edition > cervical cancer > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Presence of Nuclear Atypia Not an Indication of Progression for Low-Grade Cervical Lesions: Presented at ASCP

          By John Otrompke

          CHICAGO -- November 5, 2009 -- Marked nuclear atypia in low-grade lesions are not an indication that the lesions will progress to become high-risk tumours, although they do serve as predictors that the low-grade lesions will recur, researchers noted at the American Society for Clinical Pathology (ASCP) 2009 Annual Meeting. There was no association between human papillomavirus (HPV) and nuclear atypia, either.

          "Some nuclear features are uglier than others," explained Major Rosemarie Rodriguez, MD, Brooke Army Medical Center, Fort Sam Houston, San Antonio, Texas, at a presentation on October 29. "We were trying to see whether the uglier it gets, does it mean anything? In other words, would low-grade cervical lesions with nuclear atypia eventually develop into high-grade lesions? … It didn't pan out that way."

          The study examined 352 consecutive cervical biopsies, divided into 321 cases without marked nuclear atypia, and 31 with atypia (defined as cases with at least 5 epithelial cells with nuclear enlargement and/or multinucleation of at least 5 nuclei). Average follow-up was 14.3 months for those with atypia and 17.9 months for those without atypia.

          High-grade squamous intraepithelial lesions developed in 10.34% of the cases with atypia and 11.68% of those without atypia. While low-grade lesions recurred in 19 of 29 cases with marked nuclear atypia, they recurred in only 114 of 291 cases without atypia (P = .009).

          No significant differences in HPV load were found between the 2 groups.

          "We did follow up the cases for 24 months," said Dr. Rodriguez, noting that a contrary finding would have been significant, because it may have indicated that more frequent follow-up -- such as Pap smears twice a year, or a surgical procedure -- would have been called for. "Being in the military, you can't say no to your Pap test. Whatever diagnosis you get, you can't escape the follow-up," she added.

          According to the literature, 60% of cases of low-grade lesions regress and 30% persist, while between 11% and 13% progress to high-grade lesions that can develop into cervical cancer.

          [Presentation title: The Significance of Marked Nuclear Atypia in Grade 1 Cervical Intraepithelial Neoplasia. Abstract 26]




        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send